Care Coordination Program for Dementia

(Co-CARE-AD Trial)

Overseen by Richard Platt, MD MS

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: Harvard Pilgrim Health Care

No Placebo Group

Trial Summary

What is the purpose of this trial?

This is a randomized, pragmatic clinical trial to evaluate the effectiveness of a collaborative care-coordination program embedded in a health plan for people living with Alzheimer's disease and related dementias (ADRD) and their care partners versus usual care. The study population will include community-dwelling Medicare Advantage members living with ADRD and their care partners. Outcomes will be healthcare utilization outcomes of individuals with ADRD and include emergency department visits, outpatient visits, avoidable emergency department visits, and admission to long-term care facilities.

Research Team

Xiaojuan Li, PhD MSPH

Principal Investigator

Harvard Pilgrim Health Care Institute

Richard Platt, MD MS

Principal Investigator

Harvard Pilgrim Health Care Institute

Eligibility Criteria

This trial is for community-dwelling individuals enrolled in the Tufts Health Plan Medicare Advantage who have Alzheimer's disease or related dementias, along with their caregivers. Participants must meet certain health plan criteria to join.

Inclusion Criteria

Community-dwelling Tufts Health Plan Medicare Advantage members with ADRD and their caregivers will be selected to participate in the trial based on the following inclusion/

Treatment Details

Interventions

• Dementia Care Consultation program (Behavioral Intervention)

Trial Overview The study is testing a Dementia Care Consultation program designed to help manage Alzheimer's and related dementias. It compares this new care-coordination approach against the usual healthcare services provided by the health plan.

Participant Groups

Group I: Dementia Care Consultation program Experimental Treatment 1 Intervention

The Dementia Care Consultation program provides an in-depth, personalized service for individuals and families facing ADRD.

Group II: Routine Care Active Control 1 Intervention

Members randomized into the control group will receive routine care.

Who Is Running the Clinical Trial?

Harvard Pilgrim Health Care

Lead Sponsor

Trials

61

Recruited

27,990,000+

Cain Hayes

Harvard Pilgrim Health Care

Chief Executive Officer since 2021

MBA from Webster University

Michael Sherman

Harvard Pilgrim Health Care

Chief Medical Officer since 2018

MD from Yale School of Medicine

Tufts Health Plan

Collaborator

Trials

1

Recruited

2,200+

National Institute on Aging (NIA)

Collaborator

Trials

1,841

Recruited

28,150,000+

Dr. Richard J. Hodes

National Institute on Aging (NIA)

Chief Executive Officer since 1993

MD from Harvard Medical School

Dr. Marie Bernard

National Institute on Aging (NIA)

Chief Medical Officer

MD from Harvard Medical School